NO20072719L - Serumfritt cellekulturmedium for pattedyrceller - Google Patents

Serumfritt cellekulturmedium for pattedyrceller

Info

Publication number
NO20072719L
NO20072719L NO20072719A NO20072719A NO20072719L NO 20072719 L NO20072719 L NO 20072719L NO 20072719 A NO20072719 A NO 20072719A NO 20072719 A NO20072719 A NO 20072719A NO 20072719 L NO20072719 L NO 20072719L
Authority
NO
Norway
Prior art keywords
serum
mammalian cells
culture medium
cell culture
free cell
Prior art date
Application number
NO20072719A
Other languages
English (en)
Other versions
NO341236B1 (no
Inventor
Jose Casatorres Hernandez
Carlos Martin Piera
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20072719L publication Critical patent/NO20072719L/no
Publication of NO341236B1 publication Critical patent/NO341236B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormones [GH] (Somatotropin)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/825Metallothioneins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0043Medium free of human- or animal-derived components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/005Protein-free medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/22Zinc; Zn chelators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/36Lipids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/04Immortalised cells

Abstract

Denne oppfinnelsen vedrører en fremgangsmåte for fremstilling av et protein i mammalske celler kultivert i serumfritt medium.
NO20072719A 2004-11-02 2007-05-29 Fremgangsmåte for produksjon av veksthormon og anvendelse derav NO341236B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04105451 2004-11-02
US62488504P 2004-11-04 2004-11-04
PCT/EP2005/055637 WO2006108455A1 (en) 2004-11-02 2005-10-28 Serum-free cell culture medium for mammalian cells

Publications (2)

Publication Number Publication Date
NO20072719L true NO20072719L (no) 2007-05-29
NO341236B1 NO341236B1 (no) 2017-09-25

Family

ID=34981827

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072719A NO341236B1 (no) 2004-11-02 2007-05-29 Fremgangsmåte for produksjon av veksthormon og anvendelse derav

Country Status (20)

Country Link
US (1) US7709229B2 (no)
EP (1) EP1807504B1 (no)
JP (1) JP4833991B2 (no)
KR (1) KR101196103B1 (no)
CN (1) CN101052708B (no)
AR (1) AR052028A1 (no)
AT (1) ATE499434T1 (no)
AU (1) AU2005330353B2 (no)
CA (1) CA2583027A1 (no)
DE (1) DE602005026548D1 (no)
DK (1) DK1807504T3 (no)
ES (1) ES2361559T3 (no)
NO (1) NO341236B1 (no)
PL (1) PL1807504T3 (no)
PT (1) PT1807504E (no)
RS (1) RS51913B (no)
SI (1) SI1807504T1 (no)
UA (1) UA92157C2 (no)
WO (1) WO2006108455A1 (no)
ZA (1) ZA200702434B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090127326A (ko) * 2007-03-02 2009-12-10 와이어쓰 폴리펩티드의 생산을 위한 세포 배양물 중에서 구리 및 글루타메이트의 용도
DK2154244T3 (en) * 2007-04-26 2017-06-12 Chugai Pharmaceutical Co Ltd CELL CULTIVATION PROCEDURE WHEN AN ACID-ENRICHED MEDIUM IS USED
CN101386837B (zh) * 2007-09-12 2011-06-29 北京清大天一科技有限公司 一种动物细胞培养方法
US8039231B2 (en) * 2008-04-17 2011-10-18 Wyeth Llc Methods for enhanced production of bone morphogenetic proteins
CA2797140C (en) * 2010-04-26 2018-01-23 Novartis Ag Improved cell culture medium
CN102234627B (zh) * 2010-04-30 2015-06-03 中国科学院广州生物医药与健康研究院 一种培养基添加剂及其应用
PL2591094T3 (pl) 2010-07-08 2019-02-28 Baxalta GmbH Sposób otrzymywania rekombinowanego adamts13 w linii komórkowej
KR101591671B1 (ko) 2011-04-29 2016-02-04 바이오콘 리서치 리미티드 항체의 이질성을 감소시키는 방법 및 그 항체의 제조방법
EP2776558A4 (en) 2011-11-11 2015-04-08 Essential Pharmaceuticals Llc KIT WITH SERUMERATION AND LABILITY FACTORS
LT2970980T (lt) 2013-03-15 2018-10-25 Janssen Biotech, Inc. Gamybos būdas kontroliuoti c galinio lizino, galaktozės ir sialo rūgšties kiekį rekombinantiniuose baltymuose
USD752616S1 (en) * 2013-10-23 2016-03-29 Ares Trading S.A. Display screen with graphical user interface
CN106062205A (zh) 2013-12-20 2016-10-26 基本药品有限责任公司 细胞培养基
WO2015128314A1 (en) 2014-02-27 2015-09-03 F. Hoffmann-La Roche Ag Modulation of cell growth and glycosylation in recombinant glycoprotein production
USD779505S1 (en) 2014-11-14 2017-02-21 Dexcom, Inc. Display screen or portion thereof with graphical user interface for analyte data presentation
USD779504S1 (en) * 2014-11-14 2017-02-21 Dexcom, Inc. Display screen or portion thereof with graphical user interface for presentation of analyte data
KR101867134B1 (ko) * 2015-03-23 2018-06-12 한양대학교 산학협력단 포유류 세포를 이용하여 목적 물질을 고효율로 생산하기 위한 세포 배양 배지, 이를 이용한 세포 배양 방법 및 목적 물질의 생산 방법
AU2017241807B2 (en) 2016-03-31 2021-05-20 Sanbio, Inc. Medium, methods, cells and secreted factors for stem cell culture and therapy
CN110042137B (zh) * 2019-05-14 2023-02-28 上海赛迈生物科技有限公司 高密度灌注培养重组cho细胞生产人促卵泡激素的方法、培养基及其应用
CN114075540B (zh) * 2020-08-21 2023-10-13 苏州新微溪生物医药有限公司 全化学成分hek293细胞培养基及其应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579821A (en) * 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
WO1984002534A1 (en) * 1982-12-23 1984-07-05 Us Commerce Human growth hormone produced by recombinant dna in mouse cells
US4767704A (en) * 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
EP0217822B1 (en) * 1985-02-13 1993-05-12 Scios Nova Inc. Human metallothionein-ii promoter in mammalian expression system
US4935350A (en) * 1985-11-18 1990-06-19 Amgen Materials and methods for controlling plasmid copy number and stability
CS262822B1 (en) * 1986-10-03 1989-04-14 Kovar Jan Synthetic medium for the cultivation of myelomic cells
US5045468A (en) 1986-12-12 1991-09-03 Cell Enterprises, Inc. Protein-free culture medium which promotes hybridoma growth
NO162160C (no) 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.
NZ226414A (en) 1987-10-02 1992-07-28 Genentech Inc Cd4 peptide adhesion variants and their preparation and use
ES2092468T3 (es) 1988-01-22 1996-12-01 Zymogenetics Inc Metodos para producir analogos de receptores secretados.
US6048728A (en) 1988-09-23 2000-04-11 Chiron Corporation Cell culture medium for enhanced cell growth, culture longevity, and product expression
US5143842A (en) * 1988-11-01 1992-09-01 The University Of Colorado Foundation, Inc. Media for normal human muscle satellite cells
NO894143D0 (no) * 1988-11-18 1989-10-17 Phillips Petroleum Co Bovinmetallotionein-regulatorisk omraade.
US5834312A (en) 1990-01-29 1998-11-10 Hy-Gene, Inc. Process and media for the growth of human epithelia
JP3008208B2 (ja) * 1990-06-01 2000-02-14 武田薬品工業株式会社 新規ハイブリドーマ,その製造法および生理活性物質の製造法
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
EP0666312A1 (en) 1994-02-08 1995-08-09 Wolfgang A. Renner Process for the improvement of mammalian cell growth
PT802257E (pt) 1996-04-19 2003-01-31 Nestle Sa Linhagem imortalizada de celulas epiteliais do colon humano
EP1482031B1 (en) 1996-08-30 2015-10-28 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
EP0954563B1 (en) * 1996-10-10 2008-07-02 Invitrogen Corporation Animal cell culture media comprising plant-derived nutrients
US20030153042A1 (en) 1998-07-28 2003-08-14 California Institute Of Technology Expression of functional eukaryotic proteins
ATE384120T1 (de) 1999-08-27 2008-02-15 Invitrogen Corp Metallbindende verbindungen und deren verwendung in zusammensetzungen für zellkulturmedien
WO2002066603A2 (en) * 2001-02-15 2002-08-29 Centocor, Inc. Chemically defined medium for cultured mammalian cells
US20030096414A1 (en) 2001-03-27 2003-05-22 Invitrogen Corporation Culture medium for cell growth and transfection

Also Published As

Publication number Publication date
KR101196103B1 (ko) 2012-11-01
AU2005330353A1 (en) 2006-10-19
ATE499434T1 (de) 2011-03-15
CN101052708A (zh) 2007-10-10
DE602005026548D1 (de) 2011-04-07
EP1807504A1 (en) 2007-07-18
JP2008518592A (ja) 2008-06-05
AU2005330353B2 (en) 2010-10-14
PT1807504E (pt) 2011-03-07
NO341236B1 (no) 2017-09-25
CA2583027A1 (en) 2006-10-19
US7709229B2 (en) 2010-05-04
JP4833991B2 (ja) 2011-12-07
AR052028A1 (es) 2007-02-28
RS51913B (en) 2012-02-29
PL1807504T3 (pl) 2011-07-29
UA92157C2 (ru) 2010-10-11
CN101052708B (zh) 2012-08-29
KR20070073780A (ko) 2007-07-10
SI1807504T1 (sl) 2011-05-31
ZA200702434B (en) 2008-08-27
WO2006108455A1 (en) 2006-10-19
ES2361559T3 (es) 2011-06-20
US20080064644A1 (en) 2008-03-13
EP1807504B1 (en) 2011-02-23
DK1807504T3 (da) 2011-03-21

Similar Documents

Publication Publication Date Title
NO20072719L (no) Serumfritt cellekulturmedium for pattedyrceller
NO20064379L (no) Anvendelse av et serumfritt cellekulturmedium for produsjonen av IL-18BP i pattedyrceller
AU2019268194A1 (en) Cell culture system
ATE365793T1 (de) Verfahren zur isolierung und kulturexpansion mesenchymaler stamm-/vorläuferzellen aus nabelschnurblut sowie verfahren zur differenzierung von aus nabelschnurblut stammenden mesenchymalen stamm-/vorläuferzellen in unterschiedliche mesenchymgewebe
MX2007003906A (es) Metodos y composiciones para mejorar la produccion de proteinas recombinantes.
DK1623023T3 (da) Kulturer af E1-immortaliserede celler og fremgangsmåder til dyrkning deraf til forögelse af produktudbytter derfra
NZ597334A (en) Cell culture improvements
IL182517A0 (en) System and method for production of antibodies in plant cell culture
WO2008060541A3 (en) In vitro expansion of postpartum-derived cells using microcarriers
DK1495112T3 (da) Cellekulturmedium
WO2007016366A3 (en) Defined culture conditions of human embryonic stem cells
EP2145953A4 (en) ACELLULAR SYSTEM FOR THE SYNTHESIS OF PROTEINS FROM CULTURED MAMMAL CELLS
NZ591812A (en) Cell culture method to form aggregates
EA201170025A1 (ru) Способы повышения жизнеспособности и продукции культуры клеток
EA200900984A1 (ru) Улучшение клеточного роста
ATE536347T1 (de) Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren
MX2007005210A (es) Medio de cultivo de celula libre de suero para las celulas de los mamiferos.
SG158171A1 (en) Expansion of definitive endoderm cells
WO2005054447A3 (en) Müller stem cells
TW200745333A (en) A method using bone marrow mesenchymal stem cell and platelet glue, wherein the method needs no scaffold fabrication and no need for in vito cell culture